Asia-Pacific AKI to/on CKD Summit

2019 Asia-Pacific AKI to/on CKD Summit - exploring the very beginning
Jointly organized by Taiwan Society of Nephrology and APSN AKI Committee
 
Agenda (download here)
 
November 22, 2019 (Fri) 101 Meeting Room
 
Time Topic
13:30-17:00 Oral Communication
17:30-18:00 Cocktail Reception
18:00-18:05 Opening Remark
Kuo-Cheng Lu, MD, PhD.
President, Taiwan Society of Nephrology
Jin-Shuen Chen, MD, PhD.
Secretary General, Taiwan Society of Nephrology
18:05-18:35 Keynote Lecture: Integrated Kidney Care – A Global Perspective
Philip Li, MD.
Honorary Professor of Medicine, Chief of Nephrology and Consultant,Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong
18:35-19:00 From the Integrated Care of CKD Patients to the Status of HCV Infection in
CKD/ ESRD Patients in Taiwan
Shang-Jyh Hwang, MD, PhD.
Professor of Medicine, Division of Nephrology, Kaohsiung Medical University Hospital, Taiwan
19:00-19:30 Campaign for HCV Eradication in ESRD Patients in Taiwan
Ming-Lung Yu, MD, PhD.
Vice President, Professor of Medicine, Kaohsiung Medical University,
Division of Hepatology, Department of Medicine, Kaohsiung Medical University Hospital, Taiwan
19:30-19:40 Q&A
19:40-21:00 Welcome Party
  
 
November 23, 2019 (Sat) 201 Meeting Room
 
Time Topic
09:00-09:05 Welcome Speech
Kuo-Cheng Lu, MD, PhD.
President, Taiwan Society of Nephrology
09:05-09:10 Opening Remark
Masaomi Nangaku, MD, PhD.
President, Asian Pacific Society of Nephrology;
Professor and Head of the Division of Nephrology and Endocrinology;
Vice President of the University of Tokyo Hospital, Japan
Symposium I. AKI to CKD
Chairs: Masaomi Nangaku, Kuo-Cheng Lu 
09:10-09:30 1. Leptospirosis Kidney Disease – A Model for Understanding AKI to CKD and CKDu
Chih-Wei Yang, MD.
Professor of Medicine, Department of Nephrology, Linkou Chang Gung Memorial Hospital;
Dean, College of Medicine, Chang Gung University, Taiwan
09:30-09:50 2. Mechanisms of AKI to CKD Transition
Motoko Yanagita, MD, PhD.
Professor and Chair, Department of Nephrology, Kyoto University Graduate School of Medicine, Japan
09:50-10:10 3. Macrophages in AKI to CDK transition​
Sang Kyung Jo, MD, PhD.
Professor, Department of Internal Medicine, Korea University Medical College, Korea
10:10-10:20 Q&A 
10:20-10:40 Coffee Break 
Chairs: Philip Li, Zoltan Endre 
10:40-11:00 4. AKI-AKD-CKD Continuum – Chance to Intervene?
Mai-Szu Wu, MD.
Superintendent, Taipei Medical University Shuang Ho Hospital;
Professor, Department of Internal Medicine, College of Medicine Taipei Medical University, Taiwan
11:00-11:20 5. Post-AKI: Follow-up, Care, and Outcomes
Shuei-Liong Lin, MD, PhD.
Professor, Graduate Institute of Physiology, National Taiwan University College of Medicine, Taiwan
11:20-11:30 Q&A 
11:30-12:30 Expert Opinions I.
Moderator: Masaomi Nangaku
Panelists: Chih-Wei Yang, Kuo-Cheng Lu, Mai-Szu Wu, Motoko Yanagita, Philip Li, Sang Kyung Jo,
Shuei-Liong Lin, Zoltan Endre
Question 1: How to reduce AKI to CKD?
Question 2: How to extend CKD care forward to AKI care? 
12:30-13:30 Lunch Symposium                               
Symposium II. AKI on CKD
Chairs: Kriengsak Vareesangthip, Jin-Shuen Chen 
13:30-13:50 6. Sub-clinical AKI and CKDu – One Disease or Two?
Zoltan Endre, MD, PhD.
Head of the Department of Nephrology, Prince of Wales Hospital;
Professor of Medicine, University of New South Wales, Australia
13:50-14:10 7. How AKI Affects CKD Progression
Nattachai Srisawat, MD.
Director, Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Thailand
14:10-14:30 8. AKI on CKD – How Frequent is it?
Vincent Wu, MD, PhD.
Associate Professor, Department of Internal Medicine, National Taiwan University Hospital, Taiwan
14:30-14:40 Q&A 
14:40-15:00 Coffee Break 
Chairs: Yon Su Kim, Ying-Wei Wang 
15:00-15:20 9. Mechanisms of AKI-on-CKD
Masaomi Nangaku, MD, PhD.
President, Asian Pacific Society of Nephrology;
Professor and Head of the Division of Nephrology and Endocrinology;
Vice President of the University of Tokyo Hospital, Japan 
15:20-15:40 10. Intervening AKI on CKD
Mark Okusa, MD.
Professor of Medicine, Chief of Division of Nephrology, University of Virginia, U.S.A
15:40-15:50 Q&A 
15:50-16:50 Expert Opinions II.
Moderator: Philip Li

Panelists:  Jin-Shuen Chen, Kriengsak Vareesangthip, Mark Okusa, Masaomi Nangaku,
Nattachai Srisawat, Sunita Bavanandan, Vincent Wu, Ying-Wei Wang, Yon Su Kim, Zoltan Endre
Question 3: How to recognize and manage AKI on CKD?
Question 4: How to prevent AKI on CKD? 
16:50-17:10 Asia Pacific AKI to/on CKD Initiatives and Signing Ceremony
Masaomi Nangaku, MD, PhD.
President, Asian Pacific Society of Nephrology;
Professor and Head of the Division of Nephrology and Endocrinology, Vice President of the University of Tokyo Hospital, Japan 
17:10-17:20 Closing Remark
Philip Li, MD.
Honorary Professor of Medicine, Chief of Nephrology and Consultant, Prince of Wales Hospital,
Chinese University of Hong Kong, Hong Kong
17:20-17:25 Group Photo 

Supported by: Bureau of Foreign Trade